The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
Adenocyte, LLC · IPMN, Pancreatic · Pancreas Cancer
Not applicable
Enrolling by invitation
500
2025-03
Industry sponsor intelligence
Adenocyte, LLCClinical Pipeline.
Lead-sponsor view of Adenocyte, LLC's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 5
- Recruiting
- 0
- Active
- 4
- Completed
- 1
- Results posted
- 0
- Avg enrollment
- 12
Pipeline overview
Programs by phase and activity.
Velocity
Adenocyte, LLC trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Secretin → | 5 | 0 | 0 | 0 | 0 | 4 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
The LINFU® U.S. Registry for the in the General Population Without Risk Factors
Adenocyte, LLC · Pancreatic Cancer · Pancreatic Ductal Adenocarcinoma
Not applicable
Not yet recruiting
500
2024-07
The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
Adenocyte, LLC · Pancreatic Cancer · Jaundice
Not applicable
Not yet recruiting
1,000
2024-05
Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer
Adenocyte, LLC · Pancreatic Ductal Adenocarcinoma
Not applicable
Enrolling by invitation
500
2024-03
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
A Proof-of-Concept Study Evaluating LINFU™
Adenocyte, LLC · Pancreas Adenocarcinoma · Dysplasia
Not applicable
Completed
12
2024-02
Search sponsor records
All Adenocyte, LLC studies.
This page groups studies where Adenocyte, LLC is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
5 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT06276764The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)Mar 7, 2025NCT06276803The LINFU® U.S. Registry for the in the General Population Without Risk FactorsJul 31, 2024NCT06276738The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of DiseaseMay 14, 2024NCT04793633Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic CancerMar 12, 2024NCT05161013A Proof-of-Concept Study Evaluating LINFU™Feb 20, 2024